Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II-III Trial of Peri- or Post-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

NCT01150630 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT01150630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II-III Trial of Peri- or Post-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
August 31, 2017
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer